苗及, 凌仰之, 朱娜, 雷小平. P45017α抑制剂──17位取代甾体化合物的三维定量构效关系J. 药学学报, 2001, 36(7): 507-510.
引用本文: 苗及, 凌仰之, 朱娜, 雷小平. P45017α抑制剂──17位取代甾体化合物的三维定量构效关系J. 药学学报, 2001, 36(7): 507-510.
MIAO Ji, LING Yang-zhi, ZHU Na, LEI Xiao-ping. THREE DIMENSIONAL QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP OF P45017α INHIBITORS OF 17-SUBSTITUTED STEROIDSJ. Acta Pharmaceutica Sinica, 2001, 36(7): 507-510.
Citation: MIAO Ji, LING Yang-zhi, ZHU Na, LEI Xiao-ping. THREE DIMENSIONAL QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP OF P45017α INHIBITORS OF 17-SUBSTITUTED STEROIDSJ. Acta Pharmaceutica Sinica, 2001, 36(7): 507-510.

P45017α抑制剂──17位取代甾体化合物的三维定量构效关系

THREE DIMENSIONAL QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP OF P45017α INHIBITORS OF 17-SUBSTITUTED STEROIDS

  • 摘要: 目的 建立P45017α的17位取代甾体抑制剂的三维定量构效关系,为设计新的、更有效的抑制剂提供理论依据。方法和结果 利用比较分子力场方法,建立了P45017α抑制剂的三维定量构效关系模型。交叉验证回归系数R2CV、非交叉验证回归系数R2 和标准偏差SEE分别为0.538,0.799和0.257。说明该系列化合物分子周围立体场和静电场的分布与生物活性间有良好的相关性。用该模型对本室合成的3个化合物进行活性预测,结果与实测值相符。结论 所得模型支持了假设的抑制剂作用机理和作用模型。所得CoMFA模型有一定的预测能力,可用来指导设计新的P45017α抑制剂

     

    Abstract: AIM To develop a three dimensional quantitative structure activity relationship (3D-QSAR) model and gain further insights into the requirements for potential P45017α inhibitors. METHODS AND RESULTS A predictive 3D pharmacophore model was established based on comparative molecular field analysis (CoMFA). The correlation between the activities and structures was significant with cross validated value (R2cv), non cross validated value (R2) and standard error of estimate (SEE) of 0.538, 0.799 and 0.257, respectively. According to this model, the predicted inhibition activities of three compounds synthesized in our laboratory were compatible to actual activities. CONCLUSION This model would contribute to the understanding of the interaction between the inhibitors and P45017α and rational design of novel lead molecules.

     

/

返回文章
返回